Background: Biobanks are vital research infrastructures aiming to collect, process, store, and distribute biological specimens along with associated data in an organized and governed manner. Exploiting diverse datasets produced by the biobanks and the downstream research from various sources and integrating bioinformatics and "omics" data has proven instrumental in advancing research such as cancer research. Biobanks offer different types of biological samples matched with rich datasets comprising clinicopathologic information. As digital pathology and artificial intelligence (AI) have entered the precision medicine arena, biobanks are progressively transitioning from mere biorepositories to integrated computational databanks. Consequently, the application of AI and machine learning on these biobank datasets holds huge potential to profoundly impact cancer research. Methods: In this paper, we explore how AI and machine learning can respond to the digital evolution of biobanks with flexibility, solutions, and effective services. We look at the different data that ranges from specimen-related data, including digital images, patient health records and downstream genetic/genomic data and resulting "Big Data" and the analytic approaches used for analysis. Results: These cutting-edge technologies can address the challenges faced by translational and clinical research, enhancing their capabilities in data management, analysis, and interpretation. By leveraging AI, biobanks can unlock valuable insights from their vast repositories, enabling the identification of novel biomarkers, prediction of treatment responses, and ultimately facilitating the development of personalized cancer therapies. Conclusions: The integration of biobanking with AI has the potential not only to expand the current understanding of cancer biology but also to pave the way for more precise, patient-centric healthcare strategies.

Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking / Frascarelli, C.; Bonizzi, G.; Musico, C. R.; Mane, E.; Cassi, C.; Guerini Rocco, E.; Farina, A.; Scarpa, A.; Lawlor, R.; Reggiani Bonetti, L.; Caramaschi, S.; Eccher, A.; Marletta, S.; Fusco, N.. - In: JOURNAL OF PERSONALIZED MEDICINE. - ISSN 2075-4426. - 13:9(2023), pp. 1-11. [10.3390/jpm13091390]

Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking

Reggiani Bonetti L.;Caramaschi S.;Eccher A.;Fusco N.
2023

Abstract

Background: Biobanks are vital research infrastructures aiming to collect, process, store, and distribute biological specimens along with associated data in an organized and governed manner. Exploiting diverse datasets produced by the biobanks and the downstream research from various sources and integrating bioinformatics and "omics" data has proven instrumental in advancing research such as cancer research. Biobanks offer different types of biological samples matched with rich datasets comprising clinicopathologic information. As digital pathology and artificial intelligence (AI) have entered the precision medicine arena, biobanks are progressively transitioning from mere biorepositories to integrated computational databanks. Consequently, the application of AI and machine learning on these biobank datasets holds huge potential to profoundly impact cancer research. Methods: In this paper, we explore how AI and machine learning can respond to the digital evolution of biobanks with flexibility, solutions, and effective services. We look at the different data that ranges from specimen-related data, including digital images, patient health records and downstream genetic/genomic data and resulting "Big Data" and the analytic approaches used for analysis. Results: These cutting-edge technologies can address the challenges faced by translational and clinical research, enhancing their capabilities in data management, analysis, and interpretation. By leveraging AI, biobanks can unlock valuable insights from their vast repositories, enabling the identification of novel biomarkers, prediction of treatment responses, and ultimately facilitating the development of personalized cancer therapies. Conclusions: The integration of biobanking with AI has the potential not only to expand the current understanding of cancer biology but also to pave the way for more precise, patient-centric healthcare strategies.
2023
13
9
1
11
Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking / Frascarelli, C.; Bonizzi, G.; Musico, C. R.; Mane, E.; Cassi, C.; Guerini Rocco, E.; Farina, A.; Scarpa, A.; Lawlor, R.; Reggiani Bonetti, L.; Caramaschi, S.; Eccher, A.; Marletta, S.; Fusco, N.. - In: JOURNAL OF PERSONALIZED MEDICINE. - ISSN 2075-4426. - 13:9(2023), pp. 1-11. [10.3390/jpm13091390]
Frascarelli, C.; Bonizzi, G.; Musico, C. R.; Mane, E.; Cassi, C.; Guerini Rocco, E.; Farina, A.; Scarpa, A.; Lawlor, R.; Reggiani Bonetti, L.; Caramaschi, S.; Eccher, A.; Marletta, S.; Fusco, N.
File in questo prodotto:
File Dimensione Formato  
jpm-13-01390.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 578.59 kB
Formato Adobe PDF
578.59 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1332006
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact